SENTÉ®, an innovative specialty aesthetics company, is pleased to announce a partnership with Skinuva® as the exclusive US Professional Sales Partner of Skinuva® Scar.
Skinuva® Scar is a patented, physician-designed scar cream clinically proven to be more effective than silicone cream in improving the appearance of scars supported by 5 publications in peer-reviewed medical literature.
There has been a lack of advancement in silicone creams since their introduction in the 1990s. Skinuva® Scar is changing the way scars are treated with selective synthetic Growth Factors and other clinically proven ingredients in its formulation.
“As a long-time SENTÉ® customer in my Beverly Hills Oculoplastic practice, we could not have found a better partner and ambassador for the Skinuva® brand as we now have in SENTE®.
We are incredibly thrilled to embark on this exciting new partnership in serving our physician customers and patients across the country in 2021 and beyond”, said Dr. Christopher Zoumalan, MD FACS, Founder & President of Skinuva®.
"I switched my patients to Skinuva Scar after learning more about the science and clinical data supporting its efficacy in post-surgery patients several years ago. Comparing it to other scar creams that I've used in the past, I have noticed a superior difference in how Skinuva helps improve the appearance of scars and especially pigmentation, and I now provide it to all my post surgery patients as part of their post surgery recovery regimen.”, said Board Certified Plastic Surgeon and ASAPS member Daniel Barrett, M.D.
SENTÉ develops and sells professional grade skin care products to Medical Practices who perform aesthetic procedures. This partnership with Skinuva® provides SENTÉ the ability to meet the demands of surgeons and patients with innovative technologies for both scar management and long-term anti-aging solutions.
“The entire SENTÉ team is excited to partner with Skinuva and provide our physician network with a truly innovative scar minimizing solution backed by compelling clinical evidence. We look forward to integrating Skinuva Scar Cream in our portfolio of skin care products to serve the needs of patients post-surgery,” said Laurent Combredet, CEO of SENTÉ.
SENTÉ is a privately held specialty aesthetics company leveraging its expertise to deliver novel, science-based skin care products. SENTÉ® is a leader in the development of innovative and targeted skincare products based on glycosaminoglycan technologies. Founded in 2007 and based in San Diego, California, further information may be found at SENTÉlabs.com. SENTÉ products are available through its exclusive network of physicians and medically supervised spas.
For more information regarding Skinuva® Scar available through SENTÉ® or to provide Skinuva® to your patients, email firstname.lastname@example.org.